Authors
Evelina Tacconelli, Siri Göpel, Beryl P Gladstone, Simone Eisenbeis, Florian Hölzl, Michael Buhl, Anna Górska, Chiara Cattaneo, Alexander Mischnik, Siegbert Rieg, Anna M Rohde, Britta Kohlmorgen, Jane Falgenhauer, Janina Trauth, Nadja Käding, Evelyn Kramme, Lena M Biehl, Sarah V Walker, Silke Peter, Petra Gastmeier, Trinad Chakraborty, Maria JGT Vehreschild, Harald Seifert, Jan Rupp, Winfried V Kern, Elke Lemke, Norbert Thoma, Solvy Wolke, Can Imirzalioglu, Susanne Herold, Nicole Tewes, Moritz Fritzenwanker, Jörg Janne Vehreschild, Annika Yanina Classen, David Tobys, Paul Higgins, Yannic Blum, Matthias Kleipaß, Lisa Höltig, Katharina Nagel, Kristina Schmauder, Larissa Künstle, Elisabeth Stoll, Ariane Gertraud Dinkelacker, Gabriele Peyerl-Hoffmann, Georg Häcker, Heike Spitznagel, Sara Christina Olawumi-Hurter
Publication date
2022/5/1
Journal
The Lancet Infectious Diseases
Volume
22
Issue
5
Pages
731-741
Publisher
Elsevier
Description
Background
The burden of bloodstream infections remains high worldwide and cannot be confined to short-term in-hospital mortality. We aimed to develop scores to predict short-term and long-term mortality in patients with bloodstream infections.
Methods
The Bloodstream Infection due to Multidrug-resistant Organisms: Multicenter Study on Risk Factors and Clinical Outcomes (BLOOMY) study is a prospective, multicentre cohort study at six German tertiary care university hospitals to develop and validate two scores assessing 14-day and 6-month mortality in patients with bloodstream infections. We excluded patients younger than 18 years or who were admitted to an ophthalmology or psychiatry ward. Microbiological, clinical, laboratory, treatment, and survival data were prospectively collected on day 0 and day 3 and then from day 7 onwards, weekly. Participants were followed up for 6 months. All patients in the …
Total citations
Scholar articles
E Tacconelli, S Göpel, BP Gladstone, S Eisenbeis… - The Lancet Infectious Diseases, 2022